Last reviewed · How we verify
Colloidal Silver
At a glance
| Generic name | Colloidal Silver |
|---|---|
| Also known as | Experimental |
| Sponsor | Hôpital Universitaire Sahloul |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Efficacy of Silver Diamine Fluoride Versus Nano-Silver Fluoride in Arresting Active Dentin Caries in Primary Teeth in Young Children (NA)
- Evaluation of Different Medicaments in the Management of Necrotic Primary Molars by Lesion Sterilization and Tissue Repair (NA)
- Children Acceptance of AgNP Mouthwash Against Chlorhexidine Mouthwash (NA)
- Comparative Study of Negative-Pressure Wound Therapy Integrated With Silver Nanoparticle Spray Versus Negative-Pressure Wound Therapy in Post-Revascularization Diabetic Foot Wound Management
- The Comparative Effects of Using 0.12% Chlorhexidine and Silver Nanoparticles Mouthwashes in Medical Students (PHASE3)
- Analyzing the Effect of Disinfection Additives on the Linear Dimensional Stability of Dental Alginate Impressions: A Quasi-Experimental Comparative Study (NA)
- The Desensitising Effect of Nanosilver Fluoride in Molar-Incisor Hypomineralisation (PHASE2, PHASE3)
- Postoperative Pain and Periapical Tissue Healing (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Colloidal Silver CI brief — competitive landscape report
- Colloidal Silver updates RSS · CI watch RSS
- Hôpital Universitaire Sahloul portfolio CI